New Pricing & Reimbursement Policy To Harm Market Prospects

Pharmaceutical prices in the Czech Republic are set to significantly decline in late 2008/early 2009, as the implementation of pricing and reimbursement reforms will introduce a dual referencing system. The State Institute for Drug Control (SUKL) now has direct responsibility for drug pricing after it was transferred from the Ministry of Finance and Ministry of Health, and has employed 90 people over the past two years for this purpose. It implemented its new methodology for setting maximum prices in June 2008, reviewing 3944 products, with the first price cuts likely to be implemented in October or November 2009 following numerous

To read the full article, please choose one of the following options: